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Abstract 
Review on der(1;14)(p10 or q10;p10 or q10) 
translocation, with data on clinics 
Clinics and pathology 
Disease 
Myelodysplastic syndrome (MDS), 
myeloproliferative neoplasm (MPN), acute 
myelogenous leukemia (AML), acute lymhoblastic 
leukemia (ALL), multiple myeloma (MM) and 
lymphoma. 
Phenotype/cell stem origin 
Suggested involvement of a pluripotent stem cell. 
Epidemiology 
Most of patients (9/14) had a diagnosis of myeloid 
disorder: AML (2 patients), MDS (2 cases) and 
chronic myeloproliferative disorders (5 cases).  A 
few other cases included ALL (2 patients), MM (1 
case) and 2 cases with lymphoid malignancies.  
The male sex is prevalent (9:5); the median age at 
diagnosis is 59 years (range 10-74 years) (Table 1).  
Prognosis 
The prognostic effect of an extra 1q chromosome in 
myeloid disorders may be variable (indolent clinical 
course in MPD vs a distinct possibility of 
transformation and poor prognosis in MDS).  
The prognosis of patients with other diseases is 
unknown (sporadic cases reported). 
Cytogenetics 
Cytogenetics morphological 
Whole arm chromosome translocation showing 2 
normal copies of chromosome 1, only 1 normal 
chromosome 14 and a der(1;14) resulting in 
complete 1q trisomy. The centromeric breakpoints 
were confirmed only in sporadic cases, revealing an 
unique centromere derived from chromosome 14 
(Busson-Le Coniat et al.,1999; Djordjevic et al., 
2005; Fogu et al., 2013). The preservation of both 
chromosome 1 and 14 centromeres was not 
confirmed. 
Additional anomalies 
Sole anomaly in half cases; found in association 
with del(5q), del(7q), del(12p), del(20q), 
t(9;22)(q34;q11) in myeloid malignancies and with 
t(8;14)(q24;q32) in Burkitt lymphoma. 
Result of the chromosomal 
anomaly 
Fusion protein 
Oncogenesis 
The unbalanced 1q whole-arm translocation with 
the recipient acrocentric 14 chromosome results in 
pure trisomy of the long arm of chromosome 1. The 
main consequence of 1q trisomy is a genomic 
imbalance that may account for a proliferation 
advantage of the neoplastic clone through a gene 
dosage effect.  
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Table 1. Reported cases with der(1;14) centromere translocations involving 1p10 or 1q10. 
Abbreviations:  ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CMML, chronic myelomonocytic leukemia; F, 
female; M, male; MF, myelofibrosis; MDS, myelodysplastic syndrome; MM,  multiple myeloma; MPD, myeloproliferative disease; 
PV, polycythemia vera; PPMF, myelofibrosis after polycythemia vera; RAEB, refractory anemia with excess of blasts; RAEBt, 
refractory anemia with excess of blasts in transformation; RARS, refractory anemia with ringed sideroblasts. 
 
The consequent deregulation of several genes 
results in alteration of the balance between 
proliferation and cell death, suggesting that gene 
deregulation is the main mechanism of oncogenesis 
in 1q rearrangements, similar to numerical 
aberrations, (such as trisomy 8) observed in various  
hematologic malignancies. 
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